Skip to content

Clinical trials

Completed Schizophrenia trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Hong Kong Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20083
20102
20132
20141
20151
20171
20182
20194
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong7
The Hong Kong Polytechnic University5
Janssen Research & Development, LLC3
Chinese University of Hong Kong2
H. Lundbeck A/S2
AstraZeneca1
CHAN SAU MAN, SANDRA1
Dr WANG Shumei1
Professor Eric Y.H. Chen1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia24
Psychotic Disorders8
Cognitive Dysfunction2
Disease2
Dyskinesias1
Genetic Predisposition to Disease1
Mental Disorders1
Metabolic Syndrome1
Parkinsonian Disorders1
Recurrence1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.